Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bain

Showing results (281-290 of 303) with videos related to

Pageof 31
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2005
Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimusNazira Chatur, Alnoor Ramji, Vincent G Bain, et al.
Hepatology (Baltimore, Md.)|July 31, 2008
Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis CStefan Zeuzem, Eric M Yoshida, Yves Benhamou, et al.
Journal of Hepatology|June 25, 2003
Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon alpha for chronic hepatitis CStefan Zeuzem, E Jenny Heathcote, Mitchell L Shiffman, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 3, 2002
Late acute rejection after liver transplantation: the Western Canada experienceAlnoor Ramji, Eric M Yoshida, Vincent G Bain, et al.
Journal of Hepatology|February 21, 2006
A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patientsVincent G Bain, Kelly D Kaita, Eric M Yoshida, et al.
Mbio|April 7, 2021
Thrombospondin-1 Restricts Interleukin-36γ-Mediated Neutrophilic Inflammation during Pseudomonas aeruginosa Pulmonary InfectionHernán F Peñaloza, Tolani F Olonisakin, William G Bain, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 18, 2004
Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinomaNorman M Kneteman, José Oberholzer, Mohammed Al Saghier, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 19, 2023
BATF2 enhances proinflammatory cytokine responses in macrophages and improves early host defense against pulmonary <i>Klebsiella pneumoniae</i> infectionRick van der Geest, Hernán F Peñaloza, Zeyu Xiong, et al.
Annals of the American Thoracic Society|June 27, 2024
Inflammatory Subphenotype Is Associated with Acute Brain Dysfunction in Mechanically Ventilated PatientsNiall T Prendergast, Christopher A Franz, Caitlin Schaefer, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 27, 2005
Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trialEric M Yoshida, Paul J Marotta, Paul D Greig, et al.
Pageof 31

Showing results (281-290 of 303) with videos related to

Sort By:
Pageof 31
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2005
Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimusNazira Chatur, Alnoor Ramji, Vincent G Bain, et al.
Hepatology (Baltimore, Md.)|July 31, 2008
Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis CStefan Zeuzem, Eric M Yoshida, Yves Benhamou, et al.
Journal of Hepatology|June 25, 2003
Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon alpha for chronic hepatitis CStefan Zeuzem, E Jenny Heathcote, Mitchell L Shiffman, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 3, 2002
Late acute rejection after liver transplantation: the Western Canada experienceAlnoor Ramji, Eric M Yoshida, Vincent G Bain, et al.
Journal of Hepatology|February 21, 2006
A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patientsVincent G Bain, Kelly D Kaita, Eric M Yoshida, et al.
Mbio|April 7, 2021
Thrombospondin-1 Restricts Interleukin-36γ-Mediated Neutrophilic Inflammation during Pseudomonas aeruginosa Pulmonary InfectionHernán F Peñaloza, Tolani F Olonisakin, William G Bain, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 18, 2004
Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinomaNorman M Kneteman, José Oberholzer, Mohammed Al Saghier, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 19, 2023
BATF2 enhances proinflammatory cytokine responses in macrophages and improves early host defense against pulmonary <i>Klebsiella pneumoniae</i> infectionRick van der Geest, Hernán F Peñaloza, Zeyu Xiong, et al.
Annals of the American Thoracic Society|June 27, 2024
Inflammatory Subphenotype Is Associated with Acute Brain Dysfunction in Mechanically Ventilated PatientsNiall T Prendergast, Christopher A Franz, Caitlin Schaefer, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 27, 2005
Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trialEric M Yoshida, Paul J Marotta, Paul D Greig, et al.
Pageof 31